How We Have Treated Severe to Critically Ill Patients With Coronavirus Disease 2019 in Korea-Reference-Cited by-同舟云学术

How We Have Treated Severe to Critically Ill Patients With Coronavirus Disease 2019 in Korea

Published:2022 Issue:49 Volume:37 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Park Do Hyeon¹^ORCID,Kang Chang Kyung¹^ORCID,Choe Pyoeng Gyun¹^ORCID,Kim Nam Joong¹^ORCID,Park Wan Beom¹^ORCID,Oh Myoung-don¹^ORCID

Affiliation:

1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2022.37.e353

Reference36 articles.

1. WHO coronavirus disease (COVID-19) dashboard. World Health Organization website. Updated 2022. Accessed October 23, 2022. https://covid19.who.int/info

2. Clinical characteristics of COVID-19 patients admitted at the Korle-Bu Teaching Hospital, Accra, Ghana

3. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19

4. Clinical Characteristics and Risk Factors for Severe Disease of Coronavirus Disease 2019 in a Low Case Fatality Rate Region in Korea

5. COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. Updated 2022. Accessed October 23, 2022. https://www.covid19treatmentguidelines.nih.gov/

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of COVID-19 Therapeutics by Mechanism: From Discovery to Approval;Journal of Korean Medical Science;2024

2. High-Dose Corticosteroid Use in Severe to Critically Ill Patients With COVID-19: A Nationwide Population-Based Matched Cohort Study;Journal of Korean Medical Science;2024

3. Postcovid Guillain-Barré syndrome with severe course - case series two patients including clinical evaluation of smell and examination of olfactory event-related potentials (OERPs);Biomedical Papers;2023-04-27

4. Adverse Drug Events Associated With Remdesivir in Real-World Hospitalized Patients With COVID-19, Including Vulnerable Populations: A Retrospective Multicenter Study;Journal of Korean Medical Science;2023

5. Risk Factors for the Prescription of Ineffective Antiviral Candidates for COVID-19 During the Early Pandemic Period in Korea;Journal of Korean Medical Science;2023